Codexis (Nasdaq:CDXS) has announced that its board of directors has appointed Dr. Stephen Dilly, former CEO of Sierra Oncology, to be its president and CEO. Dilly will assume the role on August 9, 2022. Former CEO John Nicols will retire to spend more time with his family. Nichols will continue to serve on the Codexis…
GSK to purchase biopharma Sierra Oncology for $1.9 billion
GlaxoSmithKline plc (LSE/NYSE:GSK) has reached a deal to acquire Sierra Oncology (Nasdaq:SRRA) to bolster its oncology pipeline. Under the terms of the proposed deal, GSK would pay $44 per share for a total value of approximately $1.9 billion. GSK shares were mostly flat in mid-day trading, dipping 0.032% to $46.52. SRRA shares surged 38.31% to…